File Download

There are no files associated with this item.

Conference Paper: Human Papillomavirus (HPV)-16/18 AS04-adjuvanted Vaccine: Immunological Superiority of the 2-dose Schedule Versus 2-dose and 3-dose schedules of HPV-6/11/16/18 Vaccine; Results of a Randomised, Multicentre, Immunogenicity Trial Up to Month 24

TitleHuman Papillomavirus (HPV)-16/18 AS04-adjuvanted Vaccine: Immunological Superiority of the 2-dose Schedule Versus 2-dose and 3-dose schedules of HPV-6/11/16/18 Vaccine; Results of a Randomised, Multicentre, Immunogenicity Trial Up to Month 24
Authors
Issue Date2015
Citation
The 10th Asia-Pacific Congress of Medical Virology (APCMV 2015) in conjunction with the 12th Taipei International Conference on HIV/AIDS, Taipei, Taiwan, 15-18 October 2015. How to Cite?
DescriptionOral Session 2: Viral Vaccine: abstract no. OS 2-8
Persistent Identifierhttp://hdl.handle.net/10722/221584

 

DC FieldValueLanguage
dc.contributor.authorLiu, APY-
dc.contributor.authorLeung, TF-
dc.contributor.authorLim, FS-
dc.contributor.authorThollot, F-
dc.contributor.authorOh, HML-
dc.contributor.authorChan, PC-
dc.contributor.authorLee, BW-
dc.contributor.authorRombo, L-
dc.contributor.authorTan, NC-
dc.contributor.authorRouzier, R-
dc.contributor.authorDe Simoni, S-
dc.contributor.authorSuryakiran, P-
dc.contributor.authorHezareh, M-
dc.contributor.authorFolschweiller, N-
dc.contributor.authorThomas, F-
dc.contributor.authorStruyf, F-
dc.date.accessioned2015-11-30T03:39:46Z-
dc.date.available2015-11-30T03:39:46Z-
dc.date.issued2015-
dc.identifier.citationThe 10th Asia-Pacific Congress of Medical Virology (APCMV 2015) in conjunction with the 12th Taipei International Conference on HIV/AIDS, Taipei, Taiwan, 15-18 October 2015.-
dc.identifier.urihttp://hdl.handle.net/10722/221584-
dc.descriptionOral Session 2: Viral Vaccine: abstract no. OS 2-8-
dc.languageeng-
dc.relation.ispartofAsia-Pacific Congress of Medical Virology, APCMV 2015-
dc.titleHuman Papillomavirus (HPV)-16/18 AS04-adjuvanted Vaccine: Immunological Superiority of the 2-dose Schedule Versus 2-dose and 3-dose schedules of HPV-6/11/16/18 Vaccine; Results of a Randomised, Multicentre, Immunogenicity Trial Up to Month 24-
dc.typeConference_Paper-
dc.identifier.emailLiu, APY: apyliu@hku.hk-
dc.identifier.authorityLiu, APY=rp01357-
dc.identifier.hkuros256140-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats